Since World Cancer Day was annually commemorated last week, here are some grave, but illuminating, global statistics on the agonizing disease:
- Cancer remains a leading cause of death worldwide, and was responsible for 9.6 million deaths in 2018.1-2 Nearly 1 in 6 deaths is due to cancer.1-2
- The four most common cancers are lung, breast, prostate, and colorectal cancer, with lung cancer causing the most cancer deaths. Almost a quarter of all cancer deaths are lung cancers, greater than the other three types combined.3
- On a positive note, the combined cancer death rate has continuously dropped in recent years. For example, in the United States it declined by a total of 29% from 1991 to 2017.4 This is a significant number, as the combined cancer death rate from 1991 to 2015 (a 26% decrease), translated to approximately 2,378,600 fewer cancer deaths than expected, if death rates had remained at their peak.5
While we keep those sobering numbers in mind, know that vivitide is committed to supporting cancer researchers with a formidable arsenal of peptides, proteins, and related products designed to assist alleviating and reducing this devastating disease.
- One of vivitide’s flagship product lines, RGD peptides have shown to be crucial in the early detection and subsequent treatment of many types of cancer.6-9
- Cathepsin peptides and related inhibitors are another area of robust of cancer research.10
- Apoptosis (cell death) has generated interest in the mitigation of cancer’s growth.11-12
- These and many other items related to cancer research can be found here.
We hope that one day in the future, World Cancer Day commemorations will be less necessary.
- CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442
- Anticancer Agents Med Chem. 2007 Sep;7(5):552-8. doi: 2174/187152007781668706
- Mini Rev Med Chem. 2015;15(13):1073-94. doi: 2174/1389557515666150909144606
- Journal of Oncology, vol. 2019, Article ID 9367845, 2019. https://doi.org/10.1155/2019/9367845
- Sci Rep 8, 8126 (2018). https://doi.org/10.1038/s41598-018-26593-0
- Proteomics Clin Appl. 2014 Jun; 8(0): 427–437. 1002/prca.201300105
- Int J Mol Sci. 2018 Feb; 19(2): 448. 2018; doi: 3390/ijms19020448
- J Exp Clin Cancer Res. 2011; 30(1): 87. doi: 1186/1756-9966-30-87